Registration is now open for the 2022 in-person Congress taking place October 14-16. The landscape of cancer care is rapidly evolving and oncology pathways play a critical role in defining how we treat our patients. We are excited to be back in Boston for an informative and substantive three-day program.
As the official congress of the Journal of Clinical Pathways, this meeting serves as a forum for those involved in all stages of the pathway development to ask questions, learn how to measure outcomes, and explore ways to partner and expand pathway programs.
The Oncology Clinical Pathways Congress is a one-of-a-kind opportunity for all of those in cancer care to gather together and make a positive impact on the future of patient care.
Physician Emeritus, Finance & Quality Chair
Michiana Hematology-Oncology, PC
Patient Advocate Foundation
National Patient Advocate Foundation
National Comprehensive Cancer Network
Ft. Washington, Pennsylvania
National Cancer Treatment Alliance/Community Oncology Alliance
Buffalo, New York
Harvard Business School
Harvard School of Public Health and Brigham Health, Ariadne Labs
This is your chance to learn best practices and common pitfalls from those who have experienced the sourcing, design, implementation, and evaluation process through:
• Case-Based Presentations
• Roundtable Discussions
• Networking Activities
This program is designed for healthcare professionals interested in learning how to implement, maintain, and measure treatment pathways.